Atlas Trials

Danicopan Early Access Program

Clinical trial NCT05982938 · AVAILABLE

Trial details

NCT number
NCT05982938
Sponsor
Alexion Pharmaceuticals, Inc.
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Paroxysmal Nocturnal HemoglobinuriaPNHExtravascular Hemolysis

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.